FilingReader Intelligence
CR Double-Crane proposes $53.6m dividend, names new auditor
March 27, 2025 at 08:08 PM UTC•By FilingReader AI
China Resources Double-Crane Pharmaceutical (SSE:600062) has announced a proposed cash dividend of RMB 0.371 per share (approximately $0.05 USD), totaling RMB 385.41 million (approximately $53.6 million USD), for the fiscal year 2024, pending shareholder approval. This represents 23.68% of the company's net profit attributable to equity holders.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement of China Resources Double Crane on Profit Distribution Plan for 2024March 19, 2025 at 10:23 AM UTC
KPMG Huazhen: China Resources Double Crane 2024 Internal Control Audit ReportMarch 19, 2025 at 10:23 AM UTC
China Resources Double Crane 2024 Annual ReportMarch 19, 2025 at 10:23 AM UTC
KPMG Huazhen: Special statement on China Resources Double Crane's non-operating capital occupation and other related-party capital transactions in 2024March 19, 2025 at 10:23 AM UTC
Summary of China Resources Double Crane's 2024 Annual ReportMarch 19, 2025 at 10:23 AM UTC
Announcement of China Resources Double Crane on Re-appointment of Accounting FirmMarch 19, 2025 at 10:23 AM UTC
Announcement of China Resources Double Crane on the Achievement of the Conditions for Lifting the Restriction Period of the First Grant of the Second Restriction Period of the Company's 2021 Restricted Stock Incentive PlanMarch 19, 2025 at 10:23 AM UTC
Announcement of China Resources Double Crane on the repurchase and cancellation of some restricted stocks under the company's 2021 restricted stock incentive plan and adjustment of the repurchase priceMarch 19, 2025 at 10:23 AM UTC
Announcement of China Resources Double Crane on Changes in the Company's Accounting PoliciesMarch 19, 2025 at 10:23 AM UTC
Announcement of China Resources Double Crane on Change of Registered Capital and Amendment of the Company's Articles of AssociationMarch 19, 2025 at 10:23 AM UTC
SSE:600062•Shanghai Stock Exchange
News Alerts
Get instant email alerts when China Resources Double Crane Pharmaceutical publishes news
Free account required • Unsubscribe anytime